Advanced Solid Tumors with HER2-expression

People with advanced solid tumors with HER2-expression are asked to participate in a research study being conducted by Queens Hospital Center.

You may be eligible to participate in this study if you:

• Are at least ≥ 18 years of age
• Have adequate bone marrow and cardiac function
• Have adequate hepatic and renal function

You may not participate in this study if you:

• Have any prior history of interstitial lung disease, pneumonitis, or other clinically significant lung disease within 12 months
• Have any active ocular infections until resolved or any chronic corneal disorder
• Have a history of unstable central nervous system (CNS) metastases or seizure disorder
• Have any uncontrollable intercurrent illness or infection such as COVID -19
• Had major surgery within 21 days prior to first dose
• Have received radiation therapy less than 21 days prior to first dose
• Have exposed to any other investigational drug(s) or anticancer agents within 14 days
• Are known to be positive for human immunodeficiency virus (HIV), hepatitis B, or C
• Are pregnant, breast feeding or planning to become pregnant

Contact Information
Linda Bulone, Study Coordinator
Phone: (718) 883-3751